Correlation Between Exelixis and Alnylam Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Exelixis and Alnylam Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exelixis and Alnylam Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exelixis and Alnylam Pharmaceuticals, you can compare the effects of market volatilities on Exelixis and Alnylam Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exelixis with a short position of Alnylam Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exelixis and Alnylam Pharmaceuticals.
Diversification Opportunities for Exelixis and Alnylam Pharmaceuticals
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between Exelixis and Alnylam is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Exelixis and Alnylam Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alnylam Pharmaceuticals and Exelixis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exelixis are associated (or correlated) with Alnylam Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alnylam Pharmaceuticals has no effect on the direction of Exelixis i.e., Exelixis and Alnylam Pharmaceuticals go up and down completely randomly.
Pair Corralation between Exelixis and Alnylam Pharmaceuticals
Given the investment horizon of 90 days Exelixis is expected to under-perform the Alnylam Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Exelixis is 1.07 times less risky than Alnylam Pharmaceuticals. The stock trades about -0.02 of its potential returns per unit of risk. The Alnylam Pharmaceuticals is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest 24,055 in Alnylam Pharmaceuticals on November 9, 2024 and sell it today you would earn a total of 3,770 from holding Alnylam Pharmaceuticals or generate 15.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Exelixis vs. Alnylam Pharmaceuticals
Performance |
| Timeline |
| Exelixis |
| Alnylam Pharmaceuticals |
Exelixis and Alnylam Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Exelixis and Alnylam Pharmaceuticals
The main advantage of trading using opposite Exelixis and Alnylam Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exelixis position performs unexpectedly, Alnylam Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alnylam Pharmaceuticals will offset losses from the drop in Alnylam Pharmaceuticals' long position.| Exelixis vs. TG Therapeutics | Exelixis vs. Viking Therapeutics | Exelixis vs. Madrigal Pharmaceuticals | Exelixis vs. BioXcel Therapeutics |
| Alnylam Pharmaceuticals vs. ProQR Therapeutics BV | Alnylam Pharmaceuticals vs. Wave Life Sciences | Alnylam Pharmaceuticals vs. Blueprint Medicines Corp | Alnylam Pharmaceuticals vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |